🇺🇸 FDA
Patent

US 9713637

Bacillus anthracis HtrA-defective-derived vaccines

granted A61KA61K2039/522A61K39/07

Quick answer

US patent 9713637 (Bacillus anthracis HtrA-defective-derived vaccines) held by State of Israel, Prime Minister's Office, Israel Insitute For Biological Research expires Mon Jul 20 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
State of Israel, Prime Minister's Office, Israel Insitute For Biological Research
Grant date
Tue Jul 25 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 20 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
4
CPC classes
A61K, A61K2039/522, A61K39/07